BC
Boxer Capital Portfolio holdings
AUM
$2.04B
1-Year Return
108.35%
This Quarter Return
+13.07%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.14B
AUM Growth
+$279M
(+32%)
Cap. Flow
+$213M
Cap. Flow
% of AUM
18.62%
Top 10 Holdings %
Top 10 Hldgs %
68.91%
Holding
36
New
13
Increased
4
Reduced
2
Closed
1
Top Buys
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$61.4M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$34.2M |
| 3 |
BCEL
Atreca, Inc. Class A Common Stock
BCEL
|
$32.7M |
| 4 |
Milestone Pharmaceuticals
MIST
|
$29.9M |
| 5 |
Amicus Therapeutics
FOLD
|
$29M |
Top Sells
| 1 |
Biogen
BIIB
|
$47.3M |
| 2 |
uniQure
QURE
|
$26.1M |
| 3 |
ALLK
Allakos
ALLK
|
$14M |
Sector Composition
| 1 | Healthcare | 84.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
IDEAYA Biosciences
IDYA
$2.38B
| $7.61M | 0.65% |
+764,252
| New | +$7.61M |
|
27
Akero Therapeutics
AKRO
$3.58B
| $7.6M | 0.65% |
+396,695
| New | +$7.6M |
|
|
KDMN
28
DELISTED
Kadmon Holdings, Inc.
KDMN
| $7.6M | 0.65% |
+3,688,100
| New | +$7.6M |
|
29
MEI Pharma
MEIP
$139M
| $7.28M | 0.63% |
145,655
| – | – |
|
|
LJPC
30
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $5.32M | 0.46% |
+575,000
| New | +$5.32M |
|
31
KalVista Pharmaceuticals
KALV
$796M
| $4.43M | 0.38% |
200,000
| – | – |
|
32
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $3.93M | 0.34% |
290,577
| – | – |
|
33
Voyager Therapeutics
VYGR
$235M
| $2.72M | 0.23% |
+100,000
| New | +$2.72M |
|
34
Cellectar Biosciences
CLRB
$15.9M
| $2.01M | 0.17% |
+3,067
| New | +$2.01M |
|
35
Eledon Pharmaceuticals
ELDN
$162M
| $328K | 0.03% |
18,021
| – | – |
|
|
36
Biogen
BIIB
$20.6B
| – | – |
-200,000
| Closed | -$47.3M |
|